| PCSK9 and triglyceride-rich lipoprotein metabolism I Druce, H Abujrad, TC Ooi Journal of biomedical research 29 (6), 429, 2015 | 44 | 2015 |
| The effect of PCSK9 loss-of-function variants on the postprandial lipid and ApoB-lipoprotein response TC Ooi, JA Krysa, S Chaker, H Abujrad, J Mayne, K Henry, M Cousins, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3452-3460, 2017 | 43 | 2017 |
| Human serum PCSK9 is elevated at parturition in comparison to nonpregnant subjects while serum PCSK9 from umbilical cord blood is lower compared to maternal blood P Peticca, A Raymond, A Gruslin, M Cousins, E Adetola, H Abujrad, ... International Scholarly Research Notices 2013, 2013 | 33 | 2013 |
| Effect of hemodialysis on extracellular vesicles and circulating submicron particles M Ruzicka, F Xiao, H Abujrad, Y Al-Rewashdy, VA Tang, MA Langlois, ... BMC nephrology 20, 1-8, 2019 | 22 | 2019 |
| Associations between soluble LDLR and lipoproteins in a white cohort and the effect of PCSK9 loss-of-function J Mayne, TC Ooi, L Tepliakova, D Seebun, K Walker, D Mohottalage, ... The Journal of Clinical Endocrinology & Metabolism 103 (9), 3486-3495, 2018 | 19 | 2018 |
| Serum fetuin-A levels following recombinant human thyroidstimulating hormone stimulation AM Gagnon, H Abujrad, C Irobi, HA Lochnan, A Sorisky Clinical and Investigative Medicine 36 (5), E264-E268, 2013 | 8 | 2013 |
| Heterotropic Pulmonary Thyroid in the Presence of a Normally Located Multinodular Goitre H Abujrad, B Olberg, TC Ooi J Clin Case Rep 2 (7), 134, 2012 | 4 | 2012 |
| PCSK9 as a biomarker of cardiovascular disease T Ooi, H Abujrad Biomarkers in Cardiovascular Disease; Springer: Dordrecht, The Netherlands, 2016 | 3 | 2016 |
| Resolution of metabolic abnormalities during pregnancy in a patient with Gordon syndrome and KLHL3 mutation S Awad, E Keely, H Abujrad AACE Clinical Case Reports 4 (3), 235-239, 2018 | 2 | 2018 |
| Circulating PCSK 9 is lowered acutely following surgery I Druce, H Abujrad, S Chaker, H Meggison, A Hill, A Raymond, J Mayne, ... Journal of Clinical Laboratory Analysis 32 (4), e22358, 2018 | 2 | 2018 |
| A11518 Hemodialysis reduces levels of circulating microparticles in individuals with hypertension D Burger, F Xiao, H Abujrad, Y Al-Rewashdy, A Sorisky, M Ruzicka, ... Journal of Hypertension 36, e202-e203, 2018 | | 2018 |
| Soluble LDLR Associates with Multiple Lipoprotein Parameters in a Caucasian Population and its Association with Serum PCSK9 is Affected by PCSK9 Loss of Function J Mayne, L Tepliakova, D Seebun, K Walker, D Mohottalage, Z Ning, ... Atherosclerosis Supplements 32, 9, 2018 | | 2018 |
| Soluble LDLR is Reduced by Statin Therapy; Exploration of the Modulation of LDLR Shedding as a Mechanism of Action of an Established Lipid Therapy J Mayne, L Tepliakova, K Walker, D Seebun, D Mohottalage, Z Ning, ... Atherosclerosis Supplements 32, 59-60, 2018 | | 2018 |
| Effect of hemodialysis on circulating submicron particle levels D Burger, F Xiao, H Abujrad, Y Al-Rewashdy, M Ruzicka, A Sorisky, ... Journal of Extracellular Vesicles 7, 123-123, 2018 | | 2018 |
| Serum PCSK9 in Patients With Chronic Kidney Disease on Hemodialysis H Abujrad, J Mayne, M Ruzicka, M Cousins, R Angela, J Cheesman, ... Canadian Journal of Cardiology 10 (29), S179, 2013 | | 2013 |
